Trauma and Critical Care Exposure Examined With PET (TRAPETS)
Launched by KAROLINSKA UNIVERSITY HOSPITAL · Feb 16, 2022
Trial Information
Current as of November 11, 2025
Recruiting
Keywords
ClinConnect Summary
The TRAPETS trial is studying how trauma and serious illness affect the brain and thinking abilities. Researchers want to learn more about the impact of being in an intensive care unit (ICU) after a traumatic injury. To do this, they will closely examine twenty trauma patients over a year using special imaging tests, brain activity monitoring, and cognitive tests. These examinations will take place within three weeks of the injury, then again after three months, and finally after twelve months.
To participate in this study, patients must be between 20 and 60 years old and have experienced a significant injury. They should also be able to provide informed consent, meaning they understand the study and agree to take part. Those with certain pre-existing conditions, such as severe mental health disorders or a history of serious brain injuries, cannot join the trial. Participants can expect regular check-ups and tests that will help researchers understand how trauma affects both the brain and the body over time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients 20-60 years of age.
- • 2. Trauma with an ISS score of ≥15
- • 3. Informed consent
- Exclusion Criteria:
- • 1. Patient´s refusal to participate in the trial
- • 2. Any traumatic brain or spinal injury prior to admission
- • 3. Disabling neuropsychiatric disorder (dementia-diagnosis, Mb Alzheimer, Mb Parkinson, schizophrenia or severe mental depression prior to ICU admission)
- • 4. Any preadmission history of stroke with neurological sequelae
- • 5. Co-morbidities prior to ICU admission such as severe cardiac, hepatic, hematological or renal impairment
- • 6. Terminal phase of chronic disease or malignancy
- • 7. High-dose steroid treatment before ICU admission or during ICU care
- • 8. Presumed uncooperativeness or legal incapacity
About Karolinska University Hospital
Karolinska University Hospital is a leading academic medical center in Sweden, renowned for its commitment to advanced healthcare research and innovative clinical practices. As a key sponsor of clinical trials, the hospital leverages its extensive expertise in medical research and collaboration with Karolinska Institutet, one of the world's foremost medical universities. The institution is dedicated to enhancing patient care through rigorous scientific investigation, focusing on a wide range of therapeutic areas. With a multidisciplinary approach and a strong emphasis on translational medicine, Karolinska University Hospital aims to bridge the gap between laboratory findings and clinical application, ultimately striving to improve health outcomes and advance medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, Sweden
Patients applied
Trial Officials
Lars I Eriksson, Professor
Study Chair
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials